Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Chem Biol Drug Des. 2011 Oct 31;78(6):1014–1021. doi: 10.1111/j.1747-0285.2011.01240.x

Figure 1.

Figure 1

Sequences of the 16mer Nrf2 peptide (residues 69–84) and its N-terminal deletion peptides designed and synthesized, all containing the key binding motif ETGE (A) and the 9mer Nrf2 peptide and its analogues with modification on the N-terminus and the C-terminus (B).